{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-23-001207","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2023-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.587792+00:00","generated_at":"2026-06-13T13:18:19.295900+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Artelo Biosciences annual meeting elects all 7 directors and ratifies auditor","bullets":["Quorum of 39.2% (1,120,239 shares represented) at June 30, 2023 meeting.","Class I nominees elected: R. Martin Emanuele (307,104 for), Steven Kelly (299,201).","Class II nominees elected: Douglas Blayney (279,185), Connie Matsui (291,763).","Class III nominees elected: Gregory R. Ryes (307,036), Tamara A. Favorito (297,799), Gregory D. Gorgas (272,159).","Malone Bailey LLP ratified as auditor with 1,049,839 for, 41,188 against, 29,212 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-23-001207","json":"https://secwatch.observer/filing/0001640334-23-001207.json","markdown":"https://secwatch.observer/filing/0001640334-23-001207.md","text":"https://secwatch.observer/filing/0001640334-23-001207.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033423001207/0001640334-23-001207-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033423001207/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T13:18:19.295900+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1ac008c53172bb0f4af03e13547cf54ff26dc567","claim":"ARTELO BIOSCIENCES, INC. shareholders approved Election of Directors at the 2023-06-30 meeting.","evidence_excerpt":"The Class I nominees were elected by the holders of our common stock for a one-year term, to serve until the 2024 annual meeting of stockholders, the Class II nominees were elected by the holders of our common stock for a two-year term, to serve until the 2025 annual meeting of stockholders, and the Class III nominees were elected by the holders of our common stock for a three-year term, to serve until the 2026 annual meeting of stockholders, and in each case, until their respective successor, if any, is duly elected and qualified:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033423001207/0001640334-23-001207-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-30"}],"fact_type":"shareholder_vote"},{"claim_id":"da12df0a3c8642057ced4b7d55002fd49dfa43e7","claim":"ARTELO BIOSCIENCES, INC. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-06-30 meeting.","evidence_excerpt":"The appointment of Malone Bailey LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified based on the following results of voting: For Against Abstain 1,049,839 41,188 29,212","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033423001207/0001640334-23-001207-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-30"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}